Total Funding
32
9
Total FundingDebt Financing raised
Growth Score
-1 pts
Heat Score
-30 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
381530
Achelios Therapeutics is a pharmaceutical development company advancing new product concepts through preclinical and early clinical POC.
Crist J. Frangakis: Founder, President & Chief Executive OfficerPast Role: GlaxoWellcome, Section Head
Lucy Martindale: Chief Financial OfficerPast Role: LipoScience, Chief Financial Officer
About the Company
Achelios Therapeutics is a pharmaceutical development company that focuses on advancing new product concepts through the 505(b)(2) process to early clinical proof of principle followed by asset (project) sale. Achelios has adopted a semi-virtual model to control costs and advance projects by utilizing its experienced team and on-call external
pharmaceutical experts and partners. This allows the company’s management to precisely tailor project needs with the right level of expertise and/or key opinion leaders with influence at the FDA, academic medical centers, and at the level of the payer (insurance company/government).
